Mindpeak develops an AI-based visual diagnostic platform that helps pathologists analyze breast cancer in digital pathology slides. The platform identifies and quantifies tumor regions and detects breast cancer cells, producing an interpretable report with measurements like tumor size and cell counts that can integrate with existing pathology workflows. It focuses on ease of use and cost effectiveness to bring quantitative microscopic analysis into regular clinical practice, making cancer diagnostic tools accessible beyond specialized labs. Its goal is to improve breast cancer diagnostics by providing accurate, scalable visual analysis that supports faster, more consistent clinical decisions.
Company Size
11-50
Company Stage
Series A
Total Funding
$19.7M
Headquarters
Hamburg, Germany
Founded
2018
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?